Health
CSOFT’s health blog aims to provide insight into complex diseases, treatment options and regulatory developments, and other prevalent health issues people face today.
Pfizer Signs Multiyear Agreement to Make Gilead’s Covid Treatment Remdesivir
Pfizer announced today (8/7) that it has signed a multiyear agreement for Gilead’s remdesivir, a treatment for Covid. With Gilead aiming to produce enough remdesivir to treat more than 2 million patients by the end of the year, and agreeing to send almost the entirety...
FDA Issues EUA for Vela Diagnostics Covid PCR Test
The FDA issued yesterday (8/5) Emergency Use Authorization for Vela Diagnostics for the manual version of their Covid PCR test. The manual version of the test enables flexible sample processing, facilitating widespread use of the test throughout the United States. Sam...
FDA Approves of RedHill Pharma Phase 3 Study for NTM Infection
The FDA approved today (7/31) RedHill Biopharma’s investigational new drug (IND) application for phase 3 of RHB-204 for pulmonary NTM infection in adults. NTM (nontuberculous mycobacteria) is a chronic lung disease caused by environmental bacteria typically near...
Augmented Reality and Virtual Reality in Healthcare: Opening New Possibilities for Efficient Care Delivery
Across industries, including healthcare, professional translation and localization services are essential to bringing innovative products to consumers across linguistic and national borders. For the healthcare industry, however, the stakes are often much higher, as...
US House of Representatives Approves $3.2 Billion for FDA Budget
The US House of Representatives approved of a $3.2 billion budget for the FDA for the 2021 fiscal year, a $40.8 million increase from the 2020 fiscal year. The additional funding is meant to support new initiatives for greater collaboration across departments within...
Adapting Medical Communications in Japan
Japan has one of the world’s largest and most successful medical markets, with leading pharmaceutical companies including Eisai, Takeda, and Daiichi Sankyo, and medical device manufacturers like Terumo, NIPRO, and Hitachi Medico. As a founding member of the...
US Government to Pay Pharmaceutical Leader Pfizer and BioNTech Almost $2 Billion
The US government will pay American pharmaceutical leader Pfizer and German biotech BioNTech $1.95 billion USD to buy enough COVID-19 vaccines for approximately 50 million people. Pfizer and BioNTech will not receive payment until their...
Novartis Receives Approval For Asthma Medicine Enzair Breezhaler
The European Commission (EC) has granted approval for Novartis’ Enzair Breezhaler, a medicine for uncontrolled asthma. The drug therapy is utilized as a maintenance treatment for adults with asthma. “Novartis is working to reimagine medicine for people with...
How Culture Affects Genetics: Understanding the Importance of Patients’ Diverse Backgrounds
The relationship between genetics and the diversity of cultures around the world is complex. While our genetics play an important part in who we are, the culture we live in also has a direct and large influence on our overall health. The widely accepted theory that...
US House Committee on Appropriation Approves Fiscal Year 2021 FDA Funding Bill
The US House Committee on Appropriation approved a $3.212 billion budget for the 2021 fiscal year. Part of the funding bill also gives the Food and Drug Administration authority to recall unsafe prescription and over-the-counter drugs. The proposed budget also...
Categories
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com